|
DCUN1D5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.838100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.208200E-02 |
| Normal-vs-Stage2 |
7.489800E-02 |
| Normal-vs-Stage3 |
1.969640E-01 |
| Normal-vs-Stage4 |
1.765860E-02 |
| Stage1-vs-Stage2 |
7.021800E-01 |
| Stage1-vs-Stage3 |
5.468200E-01 |
| Stage1-vs-Stage4 |
8.352500E-02 |
| Stage2-vs-Stage3 |
4.636000E-01 |
| Stage2-vs-Stage4 |
1.403230E-01 |
| Stage3-vs-Stage4 |
5.994200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.577700E-03 |
| Normal-vs-AfricanAmerican |
1.117020E-01 |
| Normal-vs-Asian |
2.605600E-01 |
| Caucasian-vs-AfricanAmerican |
9.079600E-01 |
| Caucasian-vs-Asian |
9.648800E-01 |
| AfricanAmerican-vs-Asian |
9.198400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.639600E-02 |
| Normal-vs-Female |
3.757200E-03 |
| Male-vs-Female |
5.692600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.017570E-01 |
| Normal-vs-Age(41-60Yrs) |
1.631920E-02 |
| Normal-vs-Age(61-80Yrs) |
3.498200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.013800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.274600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.918200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.519800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.602800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.599000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.996600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.952600E-01 |
| Normal-vs-Grade 2 |
5.945800E-02 |
| Normal-vs-Grade 3 |
7.114200E-02 |
| Normal-vs-Grade 4 |
1.925690E-02 |
| Grade 1-vs-Grade 2 |
6.809200E-01 |
| Grade 1-vs-Grade 3 |
7.391200E-01 |
| Grade 1-vs-Grade 4 |
6.890300E-02 |
| Grade 2-vs-Grade 3 |
9.305600E-01 |
| Grade 2-vs-Grade 4 |
7.517700E-02 |
| Grade 3-vs-Grade 4 |
7.328400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.052210E-01 |
| Normal-vs-ccB subtype |
2.557500E-03 |
| ccA subtype-vs-ccB subtype |
3.768100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.582200E-02 |
| Normal-vs-N1 |
8.301700E-02 |
| N0-vs-N1 |
5.511800E-01 |
|
|
